Our Partners
Building Long-Term Value in Oncology
Long-term, science-driven investments focused on medical impact and sustainable value creation.
40
companies
supported
6
investment projects
30
years industry experience
Investment Focus
MMFO invests in early start-up companies to advance innovative oncology programs from discovery to the preclinical proof-of-concept stage, with strong biological rationale and long-term potential. Our focus lies on innovations that address unmet medical needs and contribute to improved diagnostic and therapeutic outcomes. Differentiated technology incl. new innovative targets and treatment approaches with a clear link to unmet need in oncology.
Key focus areas include:
early oncology research and target discovery
diagnostics and early detection
precision medicine approaches
technologies with clinical relevance
.png)
Why Oncology?
Cancer incidence continues to rise due to demographic changes and
aging populations. Despite significant progress, many cancer types
still lack effective diagnostics and therapies. Early-stage innovation
plays a critical role in addressing these gaps.
Our Approach
MMFO follows a disciplined, science-first investment approach. We focus on early-stage opportunities, rigorous evaluation, and long-term value creation, supporting projects that combine scientific credibility with clear clinical relevance.
Science -First Approach
Selective Investing
Long-Term Perspective
